{"transactions":[{"id":2032757,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":117305,"kind":"person","name":"Collier William H.","position":1,"cik":"0001780495","reported_name":"Collier William H.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T21:10:34.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":866000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":866000,"derivative":{"exercise_price":2.9,"expiration_date":"2033-02-01","underlying":"Common Shares","underlying_shares":866000},"source":{"system":"sec-edgar","filing":"0001447028-23-000008","document":"wf-form4_167545861445606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702823000008/wf-form4_167545861445606.xml","form_type":"4"}},{"id":2032756,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":117305,"kind":"person","name":"Collier William H.","position":1,"cik":"0001780495","reported_name":"Collier William H.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2023-02-03T21:10:34.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":216500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":216500,"source":{"system":"sec-edgar","filing":"0001447028-23-000008","document":"wf-form4_167545861445606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702823000008/wf-form4_167545861445606.xml","form_type":"4"}},{"id":2430305,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":117305,"kind":"person","name":"Collier William H.","position":1,"cik":"0001780495","reported_name":"Collier William H.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T22:55:29.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":787550,"price":2.81,"value":2213015.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options will vest and become exercisable 1/48th each month over the four year period."}],"balance_after":787550,"derivative":{"exercise_price":2.81,"expiration_date":"2032-01-20","underlying":"Common Shares","underlying_shares":787550},"source":{"system":"sec-edgar","filing":"0001447028-22-000012","document":"wf-form4_164271931496383.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702822000012/wf-form4_164271931496383.xml","form_type":"4"}},{"id":2854284,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":117305,"kind":"person","name":"Collier William H.","position":1,"cik":"0001780495","reported_name":"Collier William H.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Options","published_at":"2021-02-17T22:00:46.000Z","date":"2021-02-13","kind":"grant","acquired":true,"shares":675000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest and become exercisable 1/48th each month over the four year period."}],"balance_after":675000,"derivative":{"exercise_price":4.33,"expiration_date":"2031-02-13","underlying":"Common Stock","underlying_shares":675000},"source":{"system":"sec-edgar","filing":"0001447028-21-000010","document":"wf-form4_161359921500159.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702821000010/wf-form4_161359921500159.xml","form_type":"4"}},{"id":3022372,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":117305,"kind":"person","name":"Collier William H.","position":1,"cik":"0001780495","reported_name":"Collier William H.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Options","published_at":"2020-09-25T20:05:04.000Z","date":"2020-09-23","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on February 14, 2020, the trading day immediately preceding the date the performance based option grant was approved by the Executive Compensation and Human Resources Committee of the Board of Directors (the \"Committee\") of Arbutus Biopharma Corporation, subject to both shareholder approval of an amendment to the Registrant's 2016 Omnibus Share and Incentive Plan (the \"Plan Amendment\") and the fulfillment of certain performance criteria."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Registrant's shareholders approved the Plan Amendment on May 28, 2020. On September 23, 2020, the Committee determined that the performance criteria had been met."}],"balance_after":70000,"derivative":{"exercise_price":3.35,"expiration_date":"2030-02-17","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001447028-20-000143","document":"wf-form4_160106428541454.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702820000143/wf-form4_160106428541454.xml","form_type":"4"}},{"id":3128972,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":117305,"kind":"person","name":"Collier William H.","position":1,"cik":"0001780495","reported_name":"Collier William H.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Options","published_at":"2020-06-01T21:02:12.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":262313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on February 14, 2020, the trading day immediately preceding the date the option grant was approved by the Executive Compensation and Human Resources Committee of the Board of Directors (the \"Committee\") of Arbutus Biopharma Corporation, subject to shareholder approval of an amendment to the Registrant's 2016 Omnibus Share and Incentive Plan (the \"Plan Amendment\")."},{"field":"date","element":"transactionDate","label":"F2","text":"The option grant was approved by the Committee on February 17, 2020, subject to shareholder approval of the Plan Amendment. The Registrant's shareholders approved the Plan Amendment on May 28, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest and become exercisable as to 3/48ths of the common shares on the grant date and an additional 1/48th of the total original common shares on the 17th day of each of the next 45 months."}],"balance_after":262313,"derivative":{"exercise_price":3.35,"expiration_date":"2030-02-17","underlying":"Common Stock","underlying_shares":262313},"source":{"system":"sec-edgar","filing":"0001447028-20-000067","document":"wf-form4_159104531419172.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702820000067/wf-form4_159104531419172.xml","form_type":"4"}},{"id":3262957,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":117305,"kind":"person","name":"Collier William H.","position":1,"cik":"0001780495","reported_name":"Collier William H.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Options","published_at":"2020-02-19T13:04:31.000Z","date":"2020-02-17","kind":"grant","acquired":true,"shares":367087,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest and become exercisable 1/48th each month over the four year period."}],"balance_after":367087,"derivative":{"exercise_price":3.35,"expiration_date":"2030-02-17","underlying":"Common Stock","underlying_shares":367087},"source":{"system":"sec-edgar","filing":"0001447028-20-000028","document":"wf-form4_158211745366536.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702820000028/wf-form4_158211745366536.xml","form_type":"4"}},{"id":3478014,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":117305,"kind":"person","name":"Collier William H.","position":1,"cik":"0001780495","reported_name":"Collier William H.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-06-26T20:18:33.000Z","date":"2019-06-24","kind":"grant","acquired":true,"shares":1112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest and become exercisable as to 25% of the common shares on June 24, 2020 and as to an additional 1/48th of the total original number of common shares subject to Mr. Collier's stock option on the corresponding day of each month over the three year period thereafter, subject to Mr. Collier's continued employment with Arbutus Biopharma Corporation through the applicable vesting dates."}],"balance_after":1112000,"derivative":{"exercise_price":2.18,"expiration_date":"2029-06-24","underlying":"Common Shares","underlying_shares":1112000},"source":{"system":"sec-edgar","filing":"0001123292-19-000911","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000112329219000911/edgar.xml","form_type":"4"}}]}